Certain gut bacteria may influence the odds of developing MS, in part by altering the activity of specific immune cells, ...

Patients with previously treated metastatic pancreatic cancer lived nearly twice as long when given daraxonrasib compared ...

Sugammadex lowers the risk for postoperative pulmonary complications vs neostigmine after major abdominal or thoracic surgery in older adults.

The finding ties a highly specific food preference to major health outcomes.

Stopping aspirin early in dual antiplatelet therapy is tied to a lower risk for bleeding with no increase in ischemic risks ...

Having sexual intercourse at an earlier age may set off a chain of biological and behavioral events that accelerates the ...

VILNIUS, Lithuania, June 19, 2026 /PRNewswire/ -- Surfshark, a leading privacy protection company, has released a major upgrade to its proprietary VPN protocol, Dausos. This latest update drastically ...

Turn Therapeutics, Inc. , a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory skin diseases, today announced the completion of a comprehensive interim ...

Results highlight importance of careful evaluation of concurrent medications, researchers ...

Genmab A/S(Nasdaq: GMAB) announced today that the European Commission (EC) granted marketing authorization for TEPKINLY ® (epcoritamab) in combination with lenalidomide and rituximab (TEPKINLY + R 2 ) ...

AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization for TEPKINLY® (epcoritamab) in combination with lenalidomide and rituximab (TEPKINLY + R2) for the ...

Immunovant’s latest earnings call projected clear optimism, as management leaned into robust Phase II data for brepocitinib in cutaneous sarcoidosis and a deep pipeline of registrational trials.